Pfizer Inc (PFE_KZ)

KASE
Currency in USD
25.55
+0.02(+0.08%)
Closed

PFE_KZ Comments

Better stay aside unless you bet on both of these happens 1) another pandemic breaks out; 2) Pfizer manages to develop vaccines to effectively combat that virus. Otherwise a perennial dog
Bankrupt!?
No way they go Bankrupt But it could go as low as $22 When CEO is gone, then we have $38 stock
No one can save Pfizer unless the CEO steps down.
Saves from what?
The fall occurred as a result of Kennedy Jr.'s actions.
This is insane
Why this fall today?
Kennedy don’t believe in Vaccine
Back to the 26.00 range. Going absolutely nowhere short or long term.
In and out
Fxk this ceo
Glad im not an Investor!! Jesussssss
It's time to replace the CEO and other useless managers because they are ruining Pfizer. They lost all of their shareholders' money.
Board of Director should replace the CEO And management immediately We are tired of seeing this stock to stay at 26
Veel te laat geanticipeerd op aflopende patenten. Ik denk dat een andere CEO op zijn plaats zou zijn! Je kan wel dierenarts zijn maar dat betekent niet dat je een bedrijf goed kan leiden. Het draait in de maatschappij om presteren en dat zijn o.a. de harde cijfers!!
another year of zero growth. same CEO and management - Same results. hard to believe no changes have not been implemented.
This stock is dead money for long time Till CEO and management change to smart one
this stock îs a trash. only dividents
the CEO should step down. Pfizer is very hard to go forwards.
This stock is not going up because CEO needs to leave and needs new management
pro badge
Pfizer is paying upwards of 6% dividend and is on its 52 week low. this pharma leader is overshadowed by its COVID vaccine, sooner or later market will realize it's value and stock will reach minimum 40$ price target
One day PFE will soar like crazy
Pfizer CEO should resign like INTC CEO
Bankrupt!?
Buy with both hands. It’s on sale.
You will be down by 32% if you invested 5 years ago
Good company, low right now
Lowest stock price ever. Bankruptcy coming?
Take a look even to the Yahoo Finance article: Is Pfizer Inc. (PFE) the Best Immunotherapy Stock to Buy Now?
What do you think about Pfizer at the moment? In my opinion, it's an opportunity at this price. It seems to have solid fundamentals, has been paying excellent dividends for years, consistently invests in research and development, and is working on promising drugs. Currently, there are some challenges due to the likelihood of Kennedy becoming the U.S. Secretary of the Department of Health. However, a company like this appears to have significant experience (given its history) dealing with candidates and elected officials, whether they are “friendly” or not. The P/E for 2024 is expected to remain around 7, with a 5-year average of 8. The effective dividend yield for 2023 is 5.73%, while the TTM dividend yield is 6.73%. The P/B ratio stands at 1.52.
very good
pro badge
How about payout ratio? -360%??? Is it OK?
pro badge
Um buy.. long term science always wins.
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.